Effects of Lactobacillus paracasei N1115 on gut microbial imbalance and liver function in patients with hepatitis B-related cirrhosis

Table 3 Proportions of intestinal flora at the phylum and genus levels in all subjects in the intervention group before and after treatment

Phylum of bacteria (%)	GR	ZL	P value
Firmicutes	61.8	51.7	0.046
Bacteroidetes	25.2	35.5	0.008
Proteobacteria	10.5	5.6	0.468
Actinobacteria	1.7	4	0.057
Fusobacteria	0.3	0.8	0.494
Bacteroides	19.8	28.4	0.014
Faecalibacterium	22	17.8	0.803
Lachnospiraceae_Incertae_Sedis	4.8	5	0.001
Ruminococcaceae_uncultured	5.4	2.6	0.027
Escherichia-Shigella	5	1.8	0.348
Subdoligranulum	4.5	2.3	0.561
Prevotella	2.4	4.9	0.211
Veillonella	3	1.3	0.315
Bifidobacterium	1.6	3.9	0.039
Enterobacteriaceae_unclassified	2.6	0.7	0.629
Anaerostipes	1	0.6	0.007

GR: Before treatment with Lactobacillus paracasei N1115 (LP N1115); ZL: 3 months after treatment with LP N1115.